Symbols / LENZ Stock $9.99 +1.22% LENZ Therapeutics, Inc.

Healthcare • Biotechnology • United States • NMS
LENZ (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 313.23M Enterprise Value 21.70M Income -82.13M Sales 19.09M Book/sh 9.07 Cash/sh 9.32
Dividend Yield — Payout 0.00% Employees 152 IPO — P/E — Forward P/E -3.29
PEG — P/S 16.41 P/B 1.10 P/C — EV/EBITDA -0.24 EV/Sales 1.14
Quick Ratio 13.91 Current Ratio 14.23 Debt/Eq 0.29 LT Debt/Eq — EPS (ttm) -2.85 EPS next Y -3.03
EPS Growth — Revenue Growth — Earnings 2026-05-06 ROA -21.86% ROE -33.63% ROIC —
Gross Margin 97.81% Oper. Margin -24.22% Profit Margin 0.00% Shs Outstand 31.35M Shs Float 18.48M Short Float 49.54%
Short Ratio 7.79 Short Interest — 52W High 50.40 52W Low 8.25 Beta 2.29 Avg Volume 958.24K
Volume 943.77K Target Price $41.14 Recom Strong_buy Prev Close $9.87 Price $9.99 Change 1.22%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-23.11
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest LENZ news

No recent news from Yahoo. Try the RSS feed for latest LENZ news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-27 CHEVALLARD DANIEL R Chief Financial Officer — 7,500 $8.57 $64,275
2026-03-27 SCHIMMELPENNINK EVERT B. Chief Executive Officer — 28,089 $8.95 $251,411
2026-03-27 GEORGE JEFFREY P. Director — 5,592 $8.92 $49,890
2025-11-17 OLSSON SHAWN Officer — 10,000 $25.74 $261,022
2025-11-17 OLSSON SHAWN Officer — 10,000 $2.08 $20,800
2025-11-07 CHEVALLARD DANIEL R Chief Financial Officer — 2,198 $22.71 $50,017
2025-11-07 MCCOLLUM JAMES W Director — 10,500 $22.79 $239,278
2025-09-30 VERSANT VENTURE CAPITAL VI, L.P. Beneficial Owner of more than 10% of a Class of Security — 224,974 $45.35 $10,352,017
2025-09-18 VERSANT VENTURE CAPITAL VI, L.P. Beneficial Owner of more than 10% of a Class of Security — 135,304 $41.59 $5,714,356
2025-08-26 VERSANT VENTURE CAPITAL VI, L.P. Beneficial Owner of more than 10% of a Class of Security — 188,094 $38.97 $7,423,920
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category